Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Norman J. Siegel New Member Outstanding Science Award
Norman J. Siegel New Member Outstanding Science Award
John Howland Award
John Howland Award
Mary Ellen Avery Award
Mary Ellen Avery Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
PROSPER Diversity Award
PROSPER Diversity Award
ASPN Founders’ Award
ASPN Founders’ Award
David G. Nichols Health Equity Award
David G. Nichols Health Equity Award
ASPN Mid-Career Award
ASPN Mid-Career Award
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
Poster Icons
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
ViewAttendees 8

Emergency Medicine

Gastroenterology/Hepatology

General Pediatrics

Hematology/Oncology

Hospital Medicine

Infectious Diseases

Medical Education

Nephrology

Pharmacology and Therapeutics

Trainee

Controversies in Infectious Diseases for General Pediatrics: Debates That May Change Your Practice

Fidaxomicin as First-line Therapy for High-risk Clostridioides difficile Infection in Children and Adolescents - Con

Saturday, April 26, 2025
11:15am - 11:30am HST
Location:  Convention Center: 313 C

    Speaker(s)

  • Ted Morton, PharmD (he/him/his)

    Clinical Pharmacy Specialist and Professor
    St. Jude Children's Research Hospital
    Memphis, Tennessee, United States

    Slides Slides
Disclosure(s):
Ted Morton, PharmD: Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)